Titlebook: Heart Failure; David S. Feldman,Paul Mohacsi Book 2019 Springer Nature Switzerland AG 2019 Cardiomyopathies.Cardiovascular pharmacotherap.

漏出

书目名称Heart Failure影响因子(影响力)




书目名称Heart Failure影响因子(影响力)学科排名




书目名称Heart Failure网络公开度




书目名称Heart Failure网络公开度学科排名




书目名称Heart Failure被引频次




书目名称Heart Failure被引频次学科排名




书目名称Heart Failure年度引用




书目名称Heart Failure年度引用学科排名




书目名称Heart Failure读者反馈




书目名称Heart Failure读者反馈学科排名

四溢

Inter- and Intracellular Mechanisms of Cardiac Remodeling, Hypertrophy and Dysfunctionardiac remodeling, how they relate to cardiac disease and how they develop as a result of differential activation of signaling circuits within and between myocardial cells. We also address the regulation of cardiac contractility and cardiac metabolism and the way it changes in heart failure. We demo

书法

ADAGE

Comorbidities and Co-Existing Conditions in Heart Failure Around Pregnancyof women who develop cardiac problems during pregnancy [1]. Indeed, pregnancy challenges the cardiovascular system and may lead to disease states such as hypertensive complications with its severe forms preeclampsia and the HELLP syndrome (H: hemolysis, EL: elevated liver enzymes. low platelets coun

喃喃诉苦

Lyme-disease

decode

Pharmacotherapy in Heart Failure (I): Renin-Angiotensin-Aldosterone System (incl. ARNI), Diuretics, with reduced left-ventricular ejection fraction (LVEF). Inhibition of the renin-angiotensin-aldosteron system (RAAS) is one of the key treatment strategies in these patients. ACE-inhibition has been introduced first and is the standard to start medication reducing events in heart failure with reduc

Culmination

Pharmacotherapy in Heart Failure (II): Beta Adrenergic Blocking Drugs, Ivabradine, Hydralazine and Nm as the “fight or flight response” which became activated to react to short bursts of activity associated with “pain, hunger, fear or rage.” The principal responses seen in the cardiovascular system are an increase in heart rate and myocardial contractility, an increase in peripheral vasoconstricti

托运

Device Therapy in the Heart Failure Study, HF increased overall and SCD mortality fivefold [1]. In patients with Class II or III HF, the mode of death is more likely be to “sudden” while in patients with Class IV HF, it is more likely to be due to pump failure [2]. The most common cause of SCD is the degeneration of ventricular tachy

Capitulate